Company Profile (AI Text)
Name: Dynaris
Canonical URL: https://wefunder.com/dynaris
Updated at: 2026-06-22T05:03:21Z

Tagline: We set new standard in oxygen therapy; 7 patents, FDA, superior therapy, & more 
Elevator pitch: Founded in 2014, Dynaris has developed a new standard in oxygen delivery devices. Its patented and FDA Cleared Apogee and cannula are the first in a line of products designed to improve patient health, eliminate oxygen waste, reduce prescription costs, and provide a more comfortable therapeutic experience.

Key claims:
- Total raised on Wefunder: 179980 | citation: https://wefunder.com/dynaris#claim-total-raised
- Total investors: 43 | citation: https://wefunder.com/dynaris#claim-total-investors

Verified facts:
- Total raised on Wefunder: 179980 | observed_at: 2026-06-22T05:03:21Z | expires_at: 2026-06-23T05:03:21Z
- Total investors: 43 | observed_at: 2026-06-22T05:03:21Z | expires_at: 2026-06-23T05:03:21Z

Computed metrics:
- total_amount_raised: 179980
- total_investors: 43
- team_size: 9
- featured_investor_count: 1
- faq_count: 0
- recent_post_count: 0

Quick facts:
- FDA 510 (K), EUA, ISO-13485 Quality System, FDA registered manufacturing in-house, Ready to go! | citation: https://wefunder.com/dynaris#claim-fact-1
- 5.9 million patients on oxygen in the U.S. alone growing to over 7 million patients in 2023. | citation: https://wefunder.com/dynaris#claim-fact-2
- Protected by 7 U.S. Patents, more pending, foreign patents pending. | citation: https://wefunder.com/dynaris#claim-fact-3
- Experienced team with a history of success, from concept through acquisition. CEO has 28 patents | citation: https://wefunder.com/dynaris#claim-fact-4
- Superior oxygen therapy for patients. Sets a new therapeutic standard for oxygen patients. | citation: https://wefunder.com/dynaris#claim-fact-5
- Oxygen therapies are expanding to other areas; i.e. cluster headaches and wound healing treatments | citation: https://wefunder.com/dynaris#claim-fact-6
- Additional products in development expand our technologies into other therapeutic market segments. | citation: https://wefunder.com/dynaris#claim-fact-7